ROBERT HOLLAND: Open Payments
NPI 1457494130 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 81 payments from 10 companies in 2025. Trend: 2023 $1,374 · 2024 $1,880 · 2025 $1,659
Food & beverage: $1,654Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $540 |
| Alkermes, Inc. | 18 | $266 |
| Janssen Pharmaceuticals, Inc | 6 | $209 |
| Otsuka America Pharmaceutical, Inc. | 7 | $164 |
| Vanda Pharmaceuticals Inc. | 2 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Lundbeck LLC | 2 | $49 |
| Neos Therapeutics, LP | 1 | $29 |
Products named: VRAYLAR, ARISTADA, REXULTI, INVEGA SUSTENNA, FANAPT, COBENFY, TRINTELLIX, CAPLYTA.
Industry payments across GA — which companies pay providers there.
